Lanreotide J Code: J1932

Drug & Product Overview

HCPCS Descriptor Injection, lanreotide, (cipla), 1 mg

HCPCS Added Date October 1, 2022

Manufacturer Cipla

Route of Administration Subcutaneous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection

About Lanreotide

Lanreotide is a medication aligned to the HCPCS J Code: J1932 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the subcutaneous route and manufactured by Cipla.

According to CMS Drug Use Information: This medication is a long-acting form of lanreotide. Lanreotide is used to treat a condition called acromegaly that occurs when the body makes too much of a certain natural substance called growth hormone. It is used when surgery or radiation treatment have not been fully successful or cannot be used. Treating acromegaly helps reduce the risk of serious problems such as diabetes and heart disease. Lanreotide works by decreasing the amount of growth hormone to normal levels. This drug is not a cure for acromegaly. It is used for the long-term treatment of this condition. This medication is also used to treat certain cancer or tumors of the stomach, intestines, or pancreas. It may help to slow down the growth of these tumors. Lanreotide is also used to treat carcinoid syndrome. It may help reduce the need to use another medication to treat diarrhea or flushing caused by carcinoid syndrome.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
69097-0870-67	Lanreotide Acetate	Cipla USA Inc.	120	120 MG / 0.5 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Lanreotide Pricing & Reimbursement

J1932 Private Payer Reimbursement

$37.28 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

Lanreotide Acetate 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J1932	Cipla USA	Lanreotide Acetate	Injection, lanreotide, (cipla), 1 mg

Lanreotide CPT Administration Codes

CPT Code	Description
96401	Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic

JW / JZ modifiers apply

CMS has identified Lanreotide (J1932) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

Lanreotide Medically Unlikely Edits (MUE)

The most billing units of J1932 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

120 units / day

= 120 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

Lanreotide Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acromegaly Carcinoid Syndrome Gastroenteropancreatic Neuroendocrine Tumors

Drug Class

Somatostatin Analog [EPC]Somatostatin Receptor Agonists [MoA]

Frequently Asked Questions

Is there an available Lanreotide billing and coding guide?

Billing and coding information for Lanreotide can be found through Cipla. Visit Here →

Are there any available Lanreotide patient assistance programs?

Lanreotide patient assistance information can be found through Cipla. Visit Here →

Where can I find Lanreotide prescribing information?

Lanreotide prescribing information can be found at the link below: Visit Here →

Where can I find Lanreotide side effect information?

Information regarding Lanreotide's side effects can be found at MedlinePlus Visit Here →

Does billing Lanreotide require JZ/JW wastage modifiers?

CMS has identified Lanreotide(J1932) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.